Can a patient receiving amoxicillin for bacterial pharyngitis safely undergo a Mantoux (tuberculin skin) test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can a Patient on Amoxicillin for Pharyngitis Undergo Mantoux Testing?

Yes, a patient receiving amoxicillin for bacterial pharyngitis can safely undergo a Mantoux (tuberculin skin) test, as antibiotics do not interfere with the delayed-type hypersensitivity response that forms the basis of tuberculin testing.

Why Antibiotics Don't Affect the Mantoux Test

The Mantoux test measures a T cell-mediated memory immune response to tuberculin purified protein derivative (PPD), representing a delayed-type hypersensitivity reaction that develops in individuals previously exposed to Mycobacterium tuberculosis 1. This cellular immune response is independent of bacterial infections or antibiotic therapy.

  • Antibiotics like amoxicillin do not suppress cellular immunity or the delayed-type hypersensitivity response required for tuberculin testing 1
  • The test relies on memory T cells recognizing tuberculin antigens, a mechanism unaffected by antibacterial agents 1

Contraindications to Mantoux Testing

According to CDC guidelines, the only contraindications to tuberculin skin testing are severe adverse reactions including ulceration, necrosis, vesiculation, bullae at the test site, or anaphylactic shock from previous testing 2. Concurrent antibiotic therapy is not listed as a contraindication.

Factors That Actually Interfere With Tuberculin Testing

While amoxicillin does not affect the test, clinicians should be aware of true causes of false-negative results:

  • Live-attenuated virus vaccines (measles, mumps, rubella, varicella, yellow fever) can suppress PPD response if given within 4-6 weeks before testing 2
  • Severe immunosuppression from HIV infection, malignancy, or immunosuppressive medications may cause anergy 2
  • Overwhelming acute illness or poor nutritional status can temporarily suppress cellular immunity 2

Practical Considerations

  • Proceed with Mantoux testing using standard technique: 0.1 mL of 5 TU PPD-tuberculin injected intradermally on the volar forearm, producing a 6-10 mm wheal 2
  • Read the test at 48-72 hours after placement, measuring induration (not erythema) transversely to the long axis of the forearm 2, 3
  • Interpret based on risk factors: ≥5 mm for HIV-infected or immunosuppressed patients; ≥10 mm for high-risk groups; ≥15 mm for persons with no risk factors 4, 5

Common Pitfall to Avoid

Do not delay tuberculin testing in patients on antibiotics for routine bacterial infections like pharyngitis. The only time to consider delaying is if the patient recently received live-attenuated vaccines (within 4-6 weeks) or has severe acute illness that might cause temporary anergy 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tuberculin testing: placement and interpretation.

AAOHN journal : official journal of the American Association of Occupational Health Nurses, 1995

Guideline

Management of Latent Tuberculosis Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Positive TB Skin Test

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the procedure for ordering a Mantoux (tuberculin) skin test?
What is the role of the Mantoux test in diagnosing cutaneous tuberculosis in a patient with a compromised immune system?
What is the diagnostic approach for tuberculosis?
How is a tuberculosis (TB) skin test result interpreted in terms of induration diameter, considering patient risk factors and medical history, such as immunocompromised status or previous Bacille Calmette-Guerin (BCG) vaccination?
How is a Tuberculosis (TB) skin test measured and interpreted in individuals with a history of exposure to TB, from a region with high TB prevalence, or with a weakened immune system, considering their demographic and medical history?
In a patient with ongoing melena and labs showing hemoglobin 10.5 g/dL, leukocyte count 3.4 × 10⁹/L, platelet count 401 × 10⁹/L, D‑dimer 4000 ng/mL, prothrombin time 13.6 seconds, activated partial thromboplastin time 28.2 seconds, international normalized ratio 1.31, fibrinogen 407 mg/dL, total bilirubin 3.1 mg/dL, aspartate aminotransferase 68 U/L, and albumin 3.04 g/dL, is hemostatic correction indicated?
What is the most likely diagnosis and recommended work‑up and treatment for a patient with a positive rheumatoid factor, elevated complement C4, and erythema nodosum?
What is the appropriate management for a cheek abscess?
What is the appropriate initial work‑up for a patient with suspected Wilson disease?
Is atropine safe in patients with acute coronary syndrome?
Should the injectable vaccine be administered before the oral vaccine when both are required at the same visit?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.